$1.19B
$13.6 Billion
13.28% of portfolio
48,000
Q1 2025
Added 135.29%
$524M
$13.6 Billion
13.28% of portfolio
1,134,574
Q1 2025
Reduced 10.29%
-
$7.23 Billion
7.04% of portfolio
-
Q1 2025
Added 33.97%
$170M
$4.87 Billion
4.74% of portfolio
650,000
Q1 2025
Added 8.75%
-
$3.7 Billion
3.6% of portfolio
-
Q1 2025
Reduced 29.54%
$350M
$3.69 Billion
3.59% of portfolio
333,400
Q1 2025
Added 2.8%
-
$3.33 Billion
3.24% of portfolio
-
Q1 2025
Added 108.3%
$150M
$3.26 Billion
3.17% of portfolio
590,742
Q1 2025
Added 77.99%
$164M
$3.26 Billion
3.17% of portfolio
206,639
Q1 2025
Reduced 13.26%
$238M
$3.04 Billion
2.96% of portfolio
200,000
Q1 2025
Added 25.0%
$1.03B
$3.04 Billion
2.96% of portfolio
74,500
Q1 2025
Reduced 6.88%
-
$2.9 Billion
2.82% of portfolio
-
Q1 2025
Reduced 0.33%
$106M
$2.77 Billion
2.69% of portfolio
527,842
Q1 2025
Reduced 20.43%
$477M
$2.77 Billion
2.69% of portfolio
348,820
Q1 2025
Added 48.43%
$301M
$2.59 Billion
2.52% of portfolio
129,813
Q1 2025
Added 3.27%
$37.9M
$2.51 Billion
2.44% of portfolio
2,055,225
Q1 2025
Reduced 12.66%
$2.02B
$2.36 Billion
2.3% of portfolio
93,968
Q1 2025
Reduced 53.02%
Inhibikase Therapeutics Inc
-
$2 Billion
1.95% of portfolio
-
Q1 2025
Reduced 19.2%
$238M
$1.75 Billion
1.7% of portfolio
796,100
Q1 2025
Added 13.73%
-
$1.68 Billion
1.63% of portfolio
-
Q1 2025
New
$14.6M
$1.33 Billion
1.3% of portfolio
276,707
Q1 2025
Added 0.83%
$370M
$1.02 Billion
0.99% of portfolio
100,000
Q1 2025
New
$728M
$937 Million
0.91% of portfolio
144,628
Q1 2025
Reduced 11.87%
$133M
$914 Million
0.89% of portfolio
347,687
Q1 2025
Reduced 49.13%
Inovio Pharmaceuticals Inc
-
$845 Million
0.82% of portfolio
-
Q1 2025
Reduced 50.64%
$119M
$814 Million
0.79% of portfolio
139,942
Q1 2025
Reduced 30.03%
-
$795 Million
0.77% of portfolio
-
Q1 2025
Added 13.78%
$487M
$795 Million
0.77% of portfolio
500,000
Q1 2025
New
$219M
$738 Million
0.72% of portfolio
212,783
Q1 2025
New
$60.7M
$687 Million
0.67% of portfolio
630,183
Q1 2025
Added 17.61%
-
$666 Million
0.65% of portfolio
-
Q1 2025
New
$365M
$657 Million
0.64% of portfolio
110,000
Q4 2024
Added 266.67%
-
$615 Million
0.6% of portfolio
-
Q1 2025
Reduced 21.63%
$1.1B
$615 Million
0.6% of portfolio
20,607
Q1 2025
New
Kiora Pharmaceuticals Inc
-
$604 Million
0.59% of portfolio
-
Q1 2025
Reduced 0.16%
$189M
$581 Million
0.57% of portfolio
131,160
Q1 2025
New
$711M
$561 Million
0.55% of portfolio
102,265
Q1 2025
Reduced 43.91%
$70M
$501 Million
0.49% of portfolio
620,588
Q1 2025
Added 148.24%
-
$488 Million
0.47% of portfolio
-
Q1 2025
Reduced 9.09%
-
$414 Million
0.4% of portfolio
-
Q1 2025
Added 26.12%
$179M
$398 Million
0.39% of portfolio
483,647
Q1 2025
New
-
$394 Million
0.38% of portfolio
-
Q1 2025
New
$68.9M
$346 Million
0.34% of portfolio
238,950
Q1 2025
Added 80.55%
$117M
$344 Million
0.33% of portfolio
95,747
Q1 2025
Reduced 61.86%
$11.8M
$275 Million
0.27% of portfolio
278,188
Q1 2025
New
$394M
$249 Million
0.24% of portfolio
21,550
Q1 2025
New
$31.6M
$204 Million
0.2% of portfolio
508,266
Q1 2025
Reduced 27.39%
-
$204 Million
0.2% of portfolio
-
Q1 2025
New
$49.5M
$200 Million
0.19% of portfolio
250,000
Q1 2025
Reduced 50.0%
$3.65B
$186 Million
0.18% of portfolio
93,393
Q1 2025
Reduced 57.55%